Mangalam Drugs And Organics Limited has informed the Exchange about Copy of Newspaper Publication
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mangalam Drugs and Organics has submitted copies of newspaper advertisements published on July 12, 2025 in Loksatta, Business Standard, and Financial Express regarding NCLT-convened meetings. The meetings are for Unsecured Creditors (August 12, 2025 at 11:00 AM) and Equity Shareholders (August 12, 2025 at 12:30 PM) to approve the Scheme of Merger by Absorption of Mangalam Laboratories Private Limited (MLPL) and Shri JB Pharma Private Limited (SJPPL, formerly Shri JB Pharma LLP) with Mangalam Drugs and Organics Limited under Sections 230-232 of the Companies Act, 2013. Both meetings will be conducted through Video Conferencing. The company has also announced its 39th AGM on the same day at 2:30 PM via VC/OAVM, with August 1, 2025 fixed as the record date for final dividend entitlement.
This is a procedural update on the ongoing merger scheme. Shareholders should participate in the August 12 meetings to vote on the merger approval. Successful merger completion with MLPL and SJPPL could lead to business consolidation, while the AGM and final dividend declaration indicate regular corporate functioning.